title: Thymic marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue-type in a patient with Sjögren's syndrome and cryoglobulinaemia.
authors.forename: Emna
authors.initials: E
authors.lastname: Braham
authors.forename: Jean
authors.initials: J
authors.lastname: Capron
authors.forename: Damien
authors.initials: D
authors.lastname: Sene
authors.forename: Frédérique
authors.initials: F
authors.lastname: Capron
authors.forename: Frédéric
authors.initials: F
authors.lastname: Davi
authors.forename: Frédéric
authors.initials: F
authors.lastname: Charlotte
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D018951:Antigens, CD20 / Q000276:immunology; D000971:Antineoplastic Combined Chemotherapy Protocols; D014408:Biomarkers, Tumor / Q000378:metabolism; D003449:Cryoglobulinemia / Q000150:complications / Q000378:metabolism / Q000473:pathology*; D004273:DNA, Neoplasm / Q000032:analysis; D005260:Female; D015321:Gene Rearrangement; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007143:Immunoglobulin Heavy Chains; D018442:Lymphoma, B-Cell, Marginal Zone / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D008875:Middle Aged; D010950:Plasma Cells / Q000473:pathology; D012859:Sjogren's Syndrome / Q000150:complications / Q000378:metabolism / Q000473:pathology*; D013953:Thymus Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D018951:Antigens, CD20; D014408:Biomarkers, Tumor; D004273:DNA, Neoplasm; D005938:Glucocorticoids; D007143:Immunoglobulin Heavy Chains